A Sacramento, Calif., federal jury on Friday concluded that Chiron Corp. did not invent the technology underlying Genentech's Herceptin breast cancer drug, freeing Genentech from having to fork over more than $300 million in royalties. "This is a case where Chiron tried to rewrite history, and they got caught," said Genentech attorney Henry Bunsow. Chiron plans to fight the verdict.
September 09, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The premier educational and networking event for employee benefits brokers and agents.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession in Georgia.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania with their dedication to law.
McGovern Legal Services, LLC seeks an attorney to join our team at our North Brunswick office working with Condominium Associations, Homeown...
Auto defense firm seeks experienced TRIAL ATTORNEY to do trials,motions, court appearances and depositions. Email resume: [email protected]
Mineola firm with national practice seeks talented, experienced (3-5 years post-admission) attorneys withdeposition experience to handle com...
Lawrence Law LLC congratulates Jeralyn Lawrence, Esq. on her upcoming installation as President of the New Jersey State Bar Association
RAYNES & LAWN is Proud to Welcome Next Generation to the Firm